PLAINSBORO, N.J., Aug. 12, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it signed a three-year contract for JARIT® surgical instruments with Amerinet, a leading national healthcare group purchasing organization (GPO).
"We are very pleased that Amerinet, one of the nation's largest GPOs, has selected Integra as a contracted supplier of our JARIT® brand of surgical instruments. This is a new contract position for the two organizations and confirms our mutual commitment to provide surgeons with the highest quality products and service," said Dan Reuvers, President, Integra Surgical.
Integra Surgical is a leading provider of surgical instruments used in general surgery, neurosurgery, cardiac surgery and most other surgical modalities. The company also produces the Omni-Tract® family of retractor systems and LUXTEC® illumination products. Please visit www.integrasurgical.com for more information.
About Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation, a world leader in regenerative medicine, is a global medical device company dedicated to improving the quality of life for millions of patients every year. Integra's products are used primarily in orthopedics, neurosurgery and general surgery. Headquartered in Plainsboro, New Jersey, Integra has research and manufacturing facilities throughout the world. Please visit www.integralife.com for more information.
About Amerinet
As a leading national healthcare group purchasing organization, Amerinet strategically partners with acute and alternate care providers to reduce costs and improve quality through its performance solutions. Built on a foundation of data, savings and trust, and supported by a team of clinical and supply chain experts, Amerinet enriches healthcare delivery for its members and the communities they serve. To learn more about the Amerinet difference, visit www.amerinet-gpo.com.
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements concerning the products and services provided by Integra. Such forward looking statements involve risks and uncertainties that could cause actual results to differ materially from predicted or expected results. Among other things, the willingness of surgical professionals to use JARIT® brand surgical instruments, LUXTEC® illumination products, and Omni-Tract® retractor systems may affect the prospects for their use in surgical procedures. In addition, the economic, competitive, governmental, technological and other factors, identified under the heading "Risk Factors" included in Item IA of Integra's Annual Report on Form 10-K for the year ended December 31, 2009 and information contained in subsequent filings with the Securities and Exchange Commission could affect actual results.
IART-P